Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Gastrointestinal 1

Conditions

Breast Neoplasms 3Colorectal Neoplasms 1

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Has results × Omacor × Clear all
NCT04268134 2026-05-06

ALTA

University of Michigan Rogel Cancer Center

Phase 2 Completed
77 enrolled 13 charts
Breast

Breast Neoplasms

NCT01661764 2018-06-08

Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention

Vanderbilt University Medical Center

Phase 2 Completed
141 enrolled 16 charts
Gastrointestinal

Colorectal Neoplasms

NCT01252290 2016-12-16

Breast Cancer Risk Biomarkers in Postmenopausal Women

University of Kansas Medical Center

Phase 2 Completed
35 enrolled 13 charts
Breast

Breast Neoplasms

NCT01252277 2016-07-21

Breast Cancer Risk Biomarkers in Premenopausal Women

University of Kansas Medical Center

Phase 2 Completed
36 enrolled 11 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡